William Lowry

Pelage Pharmaceuticals, Inc. is an American Los Angeles-based company that aims to deliver a scientifically-based, clinically-tested treatment for hair loss. The company's drug targets hair follicle stem cells responsible for hair growth, which is a novel mechanism for activating stem cells. The drug has the potential to promote robust hair growth in various forms of alopecia, including male and female pattern balding. Pelage Pharmaceuticals' topical small molecule drug platform stimulates hair growth without the need for invasive procedures or unwanted oral-systemic exposure. The company was founded by Heather Christofk, Michael Jung, William Lowry, and Daniel Gil, who has been the CEO since incorporation.